Last reviewed · How we verify

NCT07424612: CMATMCPP:ACS

Comparison of Mobile Application and Traditional Methods in Classification

Completed Last updated 24 February 2026
What this trial tests

trial testing Classification in Periodontal Disease (Diagnosis) in 122 participants. Completed in 25 December 2025.

Timeline
20 November 2024
Primary endpoint
20 December 2025
25 December 2025

Quick facts

Lead sponsorTuğba ŞAHİN
StatusCompleted
Study typeOBSERVATIONAL
Enrollment122
Start date20 November 2024
Primary completion20 December 2025
Estimated completion25 December 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Tuğba ŞAHİN

Who can join

Adults 18 to 65, any sex, with Periodontal Disease (Diagnosis). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, periodontal disease classifications of patients with periodontitis were performed using a mobile application and conventional methods. A total of 122 patients with periodontitis who presented to the Periodontology Clinic of the Faculty of Dentistry at Bolu Abant İzzet Baysal University were included in the study. The classification of periodontitis was carried out according to the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions and the EFP S3-level clinical practice guideline. In the study, periodontal classification of 122 patients with periodontitis was performed using a mobile application (Peribrain) by a student, a clinical student (manual), and a clinician (manual). In the mobile application, the following parameters were assessed: age, presence of diabetes, smoking status, deepest periodontal pocket depth, interproximal attachment loss, tooth loss, furcation defects, bite collapse, tooth migration, radiographic interproximal bone loss (%), and vertical bone loss. For classification, plaque index, gingival index, bleeding on probing, gingival recession, and clinical attachment level were measured in the patients. The results of the three groups were compared with each other.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Classification

Trials testing the same drug.

Other Tuğba ŞAHİN trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07424612.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing